St Jude reorganizes to save $50-$60 million a year, cuts 300 jobs

(Reuters) – St. Jude Medical Inc, a maker of heart devices, has realigned its product divisions into new operating units: one for implantable electronic systems and another for cardiovascular and ablation technologies. The company, which said it has eliminated about 300 jobs, expects the changes to reduce pretax operating expenses by $50 million to $60 million annually beginning in 2013. Previously, St. Jude had four divisions: cardiac rhythm management, neuromodulation, atrial fibrillation and cardiovascular. …

Analysis: Heart device troubles cloud St Jude’s outlook

CHICAGO (Reuters) – Twin setbacks for St Jude Medical Inc’s heart rhythm devices are raising concerns on Wall Street that doctors will curb use of the company’s products, weakening its position in the $6.5 billion global market for implantable defibrillators. Early last week, St Jude halted sales of its QuickSite and QuickFlex leads, wires that carry electricity from defibrillators to the heart, due to concerns the insulation could wear away and expose the wires. …